UK pharma major AstraZeneca has announced plans to invest $2 billion to expand its long-standing manufacturing footprint in ...

US clinical-stage biotech Repare Therapeutics has announced an update on the announcement on November 14 of entering into of ...

US pharma giant Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1 trillion market valuation, a sharp turnaround from this summer when its stock was hit by disappointing ...

New FIBRONEER results were presented by Boehringer Ingelheim at this year’s European Respiratory Society (ERS) International ...

USA-based Valo Health, a company using human data and AI to accelerate drug discovery and development, has announced a ...

UK-based Actimed Therapeutics, a UK-based specialty pharma company focused on bringing innovation to the treatment of cancer ...

Shares of US clinical-stage biotech Contineum Therapeutics were down 8.7% at $11.16 in pre-market activity today, after it ...

The UK subsidiary Alnylam welcomed positive Final Draft Guidance issued by the National Institute for Clinical Health and ...

Mitsubishi Tanabe Pharma has won Japanese approval for Uplizna (inebilizumab) to reduce relapse risk in immunoglobulin ...

China-headquartered Innovent Biologics has announced that the Phase III clinical trial of mazdutide, a first-in-class dual ...

Japanese drugmaker Otsuka’s subsidiaries Taiho Oncology and Taiho Pharmaceutical, along with partner US Cullinan Therapeutics ...

Japanese drugmaker Ono Pharmaceutical announced that it has received a supplemental approval for Braftovi (encorafenib) ...